Join the BioNap Email List:

Thursday, August 27, 2015

November Options Are Low Risk Way To Play Neurocrine Biosciences' Pending Catalysts

By Jason Napodano, CFA

Phase 3 KINECT-3 Data is expected late October/early November 2015. You can buy November $45 calls for $5 per contract. You can sell October $45 calls for $3.50 per contract, resulting in a net $1.50 debit. I think NBIX's stock will go to $53-56 on positive Phase 3 data.

Please read the article on Seeking-Alpha: LINK

No comments:

Post a Comment